DNLI
Denali Therapeutics Inc.
Company overview
- Market capitalization
- $3.35B
- Employees
- 507
- Latest publication
- 2026-09-29
About Denali Therapeutics Inc.
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 2,845,000USD | 2,866,000USD | 101,950,000USD | 3,045,000USD | — | — | — | 1,942,000USD |
| Gross Profit | -2,845,000USD | -2,866,000USD | -101,950,000USD | -3,045,000USD | — | — | — | -1,942,000USD |
| Research Development | 103,846,000USD | 97,905,000USD | 101,950,000USD | 102,696,000USD | 116,227,000USD | 99,787,000USD | 98,238,000USD | 91,399,000USD |
| Selling General Administrative | 33,511,000USD | 39,460,000USD | 35,484,000USD | 32,267,000USD | 29,353,000USD | 30,059,000USD | 24,949,000USD | 25,194,000USD |
| Unclassified Operating Expenses | -2,845,000USD | -2,866,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 134,512,000USD | 134,499,000USD | 137,434,000USD | 134,963,000USD | 145,580,000USD | 129,846,000USD | 123,187,000USD | 116,593,000USD |
| Operating Income | -137,357,000USD | -137,365,000USD | -137,434,000USD | -134,963,000USD | -145,580,000USD | -129,846,000USD | -123,187,000USD | -116,593,000USD |
| Interest Income | 8,910,000USD | 8,918,000USD | 10,532,000USD | 10,844,000USD | 12,610,000USD | 15,161,000USD | 15,995,000USD | 17,567,000USD |
| Net Interest Income | 8,910,000USD | 8,918,000USD | 10,532,000USD | 10,844,000USD | 12,610,000USD | 15,161,000USD | 15,995,000USD | 17,567,000USD |
| Income Before Tax | -128,447,000USD | -128,447,000USD | -126,902,000USD | -124,119,000USD | -132,970,000USD | -114,685,000USD | -107,192,000USD | -99,026,000USD |
| Net Income | -128,447,000USD | -128,549,000USD | -126,902,000USD | -124,119,000USD | -132,970,000USD | -114,753,000USD | -107,192,000USD | -99,026,000USD |
| Net Income From Continuing Ops | -128,447,000USD | -128,549,000USD | -126,902,000USD | -124,119,000USD | -132,970,000USD | -114,753,000USD | -107,192,000USD | -99,026,000USD |
| Ebit | -137,357,000USD | -128,447,000USD | -137,434,000USD | -134,963,000USD | -145,580,000USD | -129,846,000USD | -123,187,000USD | -116,593,000USD |
| Ebitda | -134,512,000USD | -124,665,000USD | -133,572,000USD | -131,007,000USD | -142,368,000USD | -127,227,000USD | -120,918,000USD | -114,651,000USD |
| Depreciation And Amortization | 2,845,000USD | 3,782,000USD | 3,862,000USD | 3,956,000USD | 3,212,000USD | 2,619,000USD | 2,269,000USD | 1,942,000USD |
| Reconciled Depreciation | 3,761,000USD | 3,782,000USD | 3,862,000USD | 3,956,000USD | 3,212,000USD | 2,619,000USD | 2,269,000USD | 1,942,000USD |
| Total Other Income Expense Net | 8,910,000USD | 8,918,000USD | 10,532,000USD | 10,844,000USD | 12,610,000USD | 15,161,000USD | 15,995,000USD | 17,567,000USD |
| Income Tax Expense | — | 102,000USD | — | — | — | 68,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 330,531,000USD | 108,463,000USD | 48,661,000USD | 335,659,000USD | 26,678,000USD | 129,160,000USD |
| Cost Of Revenue | 11,183,000USD | 7,795,000USD | 16,726,000USD | 7,032,000USD | 5,609,000USD | 212,615,000USD | 193,382,000USD | 143,183,000USD |
| Gross Profit | -11,183,000USD | -7,795,000USD | 330,531,000USD | 108,463,000USD | 48,661,000USD | 335,659,000USD | 26,678,000USD | 129,160,000USD |
| Research Development | 418,778,000USD | 396,440,000USD | 423,876,000USD | 358,732,000USD | 265,353,000USD | 212,615,000USD | 193,382,000USD | 143,183,000USD |
| Selling General Administrative | 97,104,000USD | 105,438,000USD | 103,354,000USD | 90,475,000USD | 79,059,000USD | 60,326,000USD | 46,480,000USD | 32,349,000USD |
| Unclassified Operating Expenses | 28,277,000USD | -14,537,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 544,159,000USD | 487,341,000USD | 527,230,000USD | 449,207,000USD | 344,412,000USD | 272,941,000USD | 239,862,000USD | 175,532,000USD |
| Operating Income | -555,342,000USD | -487,341,000USD | -196,699,000USD | -340,744,000USD | -295,751,000USD | 62,718,000USD | -213,184,000USD | -46,372,000USD |
| Interest Income | 42,904,000USD | 64,636,000USD | 51,505,000USD | 14,774,000USD | 4,595,000USD | 9,241,000USD | 15,219,000USD | 10,132,000USD |
| Net Interest Income | 42,904,000USD | 64,636,000USD | 45,036,000USD | 14,774,000USD | 4,595,000USD | 9,241,000USD | 15,219,000USD | 10,132,000USD |
| Income Before Tax | -512,438,000USD | -422,705,000USD | -145,194,000USD | -325,970,000USD | -291,156,000USD | 71,959,000USD | -197,965,000USD | -36,240,000USD |
| Income Tax Expense | 102,000USD | 68,000USD | 30,000USD | 21,000USD | -575,000USD | 823,000USD | -351,000USD | 10,132,000USD |
| Tax Provision | 102,000USD | 68,000USD | -6,000USD | 21,000USD | -575,000USD | 823,000USD | -351,000USD | — |
| Net Income | -512,540,000USD | -422,773,000USD | -145,224,000USD | -325,991,000USD | -290,581,000USD | 71,136,000USD | -197,614,000USD | -36,240,000USD |
| Net Income From Continuing Ops | -512,540,000USD | -422,773,000USD | -124,429,000USD | -325,991,000USD | -290,581,000USD | 72,782,000USD | -197,614,000USD | -36,240,000USD |
| Ebit | -512,438,000USD | -501,878,000USD | -196,699,000USD | -340,744,000USD | -295,751,000USD | 62,718,000USD | -213,184,000USD | -46,372,000USD |
| Ebitda | -497,626,000USD | -492,886,000USD | -179,973,000USD | -330,361,000USD | -287,158,000USD | 71,249,000USD | -205,193,000USD | -38,957,000USD |
| Depreciation And Amortization | 14,812,000USD | 8,992,000USD | 16,726,000USD | 10,383,000USD | 8,593,000USD | 8,531,000USD | 7,991,000USD | 7,415,000USD |
| Reconciled Depreciation | 14,812,000USD | 8,992,000USD | 18,640,000USD | 10,383,000USD | 8,593,000USD | 8,531,000USD | 7,991,000USD | 7,415,000USD |
| Total Other Income Expense Net | 42,904,000USD | 64,636,000USD | 51,505,000USD | 14,774,000USD | 4,595,000USD | 9,241,000USD | 15,219,000USD | 10,132,000USD |
| Interest Expense | — | — | — | 14,774,000USD | 13,188,000USD | 17,772,000USD | 15,219,000USD | 1,955,000USD |
| Net Income Applicable To Common Shares | — | — | — | -325,991,000USD | -290,581,000USD | 71,136,000USD | -197,614,000USD | -36,240,000USD |
| Non Operating Income Net Other | — | — | — | — | 4,595,000USD | 9,241,000USD | 15,219,000USD | 10,132,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,266,023,000USD | 1,144,854,000USD | 1,055,621,000USD | 1,166,241,000USD | 1,271,343,000USD | 1,374,180,000USD | 1,454,013,000USD | 1,502,565,000USD |
| Intangible Assets | 36,000,000USD | — | — | — | — | — | — | — |
| Other Current Assets | 33,468,000USD | 30,602,000USD | 32,494,000USD | 35,754,000USD | 60,712,000USD | 29,934,000USD | 32,280,000USD | 32,339,000USD |
| Total Liab | 339,925,000USD | 131,093,000USD | 129,424,000USD | 139,188,000USD | 148,657,000USD | 144,496,000USD | 135,518,000USD | 115,514,000USD |
| Total Stockholder Equity | 926,098,000USD | 1,013,761,000USD | 926,197,000USD | 1,027,053,000USD | 1,122,686,000USD | 1,229,684,000USD | 1,318,495,000USD | 1,387,051,000USD |
| Other Current Liab | 44,801,000USD | 85,475,000USD | 51,657,000USD | 71,342,000USD | 74,834,000USD | 79,037,000USD | 69,463,000USD | 52,826,000USD |
| Common Stock | 1,913,000USD | 1,888,000USD | 1,793,000USD | 1,783,000USD | 1,778,000USD | 1,768,000USD | 1,764,000USD | 1,757,000USD |
| Capital Stock | 1,913,000USD | 1,888,000USD | 1,793,000USD | 1,783,000USD | 1,778,000USD | 1,768,000USD | 1,764,000USD | 1,757,000USD |
| Retained Earnings | -2,179,971,000USD | -2,051,524,000USD | -1,922,975,000USD | -1,796,073,000USD | -1,671,954,000USD | -1,538,984,000USD | -1,424,231,000USD | -1,317,039,000USD |
| Cash | 387,626,000USD | 205,326,000USD | 90,963,000USD | 141,207,000USD | 56,947,000USD | 174,960,000USD | 90,636,000USD | 74,679,000USD |
| Cash And Short Term Investments | 987,684,000USD | 867,879,000USD | 848,204,000USD | 898,952,000USD | 817,926,000USD | 832,331,000USD | 836,559,000USD | 896,044,000USD |
| Total Current Assets | 1,022,752,000USD | 900,658,000USD | 882,598,000USD | 934,706,000USD | 878,638,000USD | 864,436,000USD | 868,839,000USD | 928,383,000USD |
| Total Current Liabilities | 110,156,000USD | 98,351,000USD | 90,146,000USD | 91,057,000USD | 91,877,000USD | 102,208,000USD | 87,093,000USD | 74,533,000USD |
| Current Deferred Revenue | 15,116,000USD | — | 22,580,000USD | — | — | — | 14,874,000USD | — |
| Net Debt | -347,579,000USD | -163,038,000USD | -46,559,000USD | -94,649,000USD | -8,315,000USD | -126,253,000USD | -38,119,000USD | -25,927,000USD |
| Short Term Debt | 9,859,000USD | 9,546,000USD | 9,164,000USD | 8,871,000USD | 8,585,000USD | 12,034,000USD | 8,036,000USD | 7,771,000USD |
| Short Long Term Debt Total | 40,047,000USD | 42,287,999USD | 44,404,000USD | 46,558,000USD | 48,632,000USD | 48,707,000USD | 52,517,000USD | 48,752,000USD |
| Long Term Investments | 63,785,000USD | 98,322,000USD | 24,703,000USD | 78,463,000USD | 235,844,000USD | 359,373,000USD | 445,463,000USD | 450,994,000USD |
| Short Term Investments | 600,058,000USD | 662,553,000USD | 757,241,000USD | 757,745,000USD | 760,979,000USD | 657,371,000USD | 745,923,000USD | 821,365,000USD |
| Net Receivables | 1,600,000USD | 2,177,000USD | 1,900,000USD | 1,400,000USD | — | 2,171,000USD | — | 1,400,000USD |
| Accounts Payable | 40,380,000USD | 3,330,000USD | 6,745,000USD | 10,844,000USD | 8,458,000USD | 11,137,000USD | 9,594,000USD | 13,936,000USD |
| Property Plant Equipment Net | 117,266,000USD | 119,935,000USD | 123,214,000USD | 130,102,000USD | 129,927,000USD | 125,630,000USD | 113,224,000USD | 72,610,000USD |
| Property Plant Equipment Gross | 117,266,000USD | 182,830,000USD | 123,214,000USD | 130,102,000USD | 129,927,000USD | 177,672,000USD | 113,224,000USD | 72,610,000USD |
| Accumulated Other Comprehensive Income | -682,000USD | 682,000USD | 1,101,000USD | 939,000USD | 2,037,000USD | 2,020,000USD | 5,529,000USD | -2,659,000USD |
| Common Stock Shares Outstanding | 186,636,978shares | 175,458,962shares | 172,421,492shares | 171,449,847shares | 171,222,030shares | 170,086,146shares | 169,456,988shares | 168,831,329shares |
| Non Current Assets Total | 243,270,999USD | 244,196,000USD | 173,023,000USD | 231,535,000USD | 392,705,000USD | 509,744,000USD | 585,174,000USD | 574,182,000USD |
| Non Current Liabilities Total | 229,769,000USD | 32,742,000USD | 39,278,000USD | 48,131,000USD | 56,780,000USD | 42,288,000USD | 48,425,000USD | 40,981,000USD |
| Non Current Liabilities Other | 5,508,000USD | 5,532,000USD | — | — | — | 5,615,000USD | — | — |
| Non Currrent Assets Other | 23,119,999USD | 22,839,000USD | 22,006,000USD | 22,970,000USD | 26,934,000USD | 24,741,000USD | 26,487,000USD | 50,578,000USD |
| Net Working Capital | 912,596,000USD | 802,307,000USD | 792,452,000USD | 843,649,000USD | 786,761,000USD | 762,228,000USD | 781,746,000USD | 853,850,000USD |
| Unclassified Non Current Assets | 3,100,000USD | 3,100,000USD | 3,100,000USD | — | — | — | — | — |
| Unclassified Non Current Liabilities | 224,261,000USD | 27,210,000USD | 39,278,000USD | 48,131,000USD | 56,780,000USD | 36,673,000USD | 48,425,000USD | 40,981,000USD |
| Unclassified Equity | 3,102,925,000USD | 3,060,827,000USD | 2,844,485,000USD | 2,818,621,000USD | 2,789,047,000USD | 2,763,112,000USD | 2,733,669,000USD | 2,703,235,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | -14,874,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,144,854,000USD | 1,374,180,000USD | 1,153,917,000USD | 1,460,242,000USD | 1,404,162,000USD | 1,604,280,000USD | 553,231,000USD | 661,984,000USD |
| Other Current Assets | 30,602,000USD | 29,934,000USD | 26,206,000USD | 26,822,000USD | 30,601,000USD | 25,958,000USD | 14,675,000USD | 7,993,000USD |
| Total Liab | 131,093,000USD | 144,496,000USD | 122,963,000USD | 417,812,000USD | 441,871,000USD | 453,749,000USD | 158,341,000USD | 115,139,000USD |
| Total Stockholder Equity | 1,013,761,000USD | 1,229,684,000USD | 1,030,954,000USD | 1,042,430,000USD | 962,291,000USD | 1,150,531,000USD | 394,890,000USD | 546,845,000USD |
| Other Current Liab | 85,475,000USD | 79,037,000USD | 61,239,000USD | 63,761,000USD | 47,712,000USD | 42,455,000USD | 20,350,000USD | 19,468,000USD |
| Common Stock | 1,888,000USD | 1,768,000USD | 1,711,000USD | 1,686,000USD | 1,548,000USD | 1,531,000USD | 1,288,000USD | 1,273,000USD |
| Capital Stock | 1,888,000USD | 1,768,000USD | 1,711,000USD | 1,686,000USD | 1,548,000USD | 1,531,000USD | 1,288,000USD | 1,273,000USD |
| Retained Earnings | -2,051,524,000USD | -1,538,984,000USD | -1,116,211,000USD | -970,987,000USD | -644,996,000USD | -354,415,000USD | -425,551,000USD | -227,937,000USD |
| Cash | 205,326,000USD | 174,960,000USD | 127,106,000USD | 218,044,000USD | 293,477,000USD | 507,144,000USD | 79,449,000USD | 77,123,000USD |
| Cash And Short Term Investments | 867,879,000USD | 832,331,000USD | 1,034,511,000USD | 1,336,215,000USD | 865,407,000USD | 1,469,697,000USD | 415,356,000USD | 464,297,000USD |
| Total Current Assets | 900,658,000USD | 864,436,000USD | 1,064,137,000USD | 1,372,319,000USD | 897,234,000USD | 1,495,655,000USD | 430,031,000USD | 480,836,000USD |
| Total Current Liabilities | 98,351,000USD | 102,208,000USD | 77,982,000USD | 363,922,000USD | 378,245,000USD | 71,699,000USD | 45,344,000USD | 32,786,000USD |
| Net Debt | -163,038,000USD | -126,253,000USD | -74,865,000USD | -157,694,000USD | -229,470,000USD | -438,279,000USD | -6,919,000USD | -77,123,000USD |
| Short Term Debt | 9,546,000USD | 12,034,000USD | 7,260,000USD | 7,318,000USD | 5,453,000USD | 4,690,000USD | 3,665,000USD | 19,088,000USD |
| Short Long Term Debt Total | 42,287,999USD | 48,707,000USD | 52,241,000USD | 60,350,000USD | 64,007,000USD | 68,865,000USD | 72,530,000USD | — |
| Long Term Investments | 98,322,000USD | 359,373,000USD | 0USD | 0USD | 425,449,000USD | 32,699,000USD | 39,886,000USD | 147,881,000USD |
| Short Term Investments | 662,553,000USD | 657,371,000USD | 907,405,000USD | 1,118,171,000USD | 571,930,000USD | 962,553,000USD | 335,907,000USD | 387,174,000USD |
| Net Receivables | 2,177,000USD | 2,171,000USD | 3,420,000USD | 9,282,000USD | 1,226,000USD | 5,674,000USD | — | 8,546,000USD |
| Accounts Payable | 3,330,000USD | 11,137,000USD | 9,483,000USD | 2,790,000USD | 4,779,000USD | 1,071,000USD | 2,590,000USD | 1,891,000USD |
| Property Plant Equipment Net | 119,935,000USD | 125,630,000USD | 71,637,000USD | 74,524,000USD | 69,608,000USD | 73,464,000USD | 80,655,000USD | 25,162,000USD |
| Property Plant Equipment Gross | 182,830,000USD | 177,672,000USD | 117,640,000USD | 74,524,000USD | 69,608,000USD | 73,464,000USD | 80,655,000USD | 14,923,000USD |
| Accumulated Other Comprehensive Income | 682,000USD | 2,020,000USD | 643,000USD | -6,886,000USD | -2,499,000USD | -245,000USD | 350,000USD | -649,000USD |
| Common Stock Shares Outstanding | 175,458,962shares | 164,473,772shares | 137,370,897shares | 125,530,703shares | 121,524,795shares | 112,703,108shares | 95,608,208shares | 92,621,991shares |
| Non Current Assets Total | 244,196,000USD | 509,744,000USD | 89,780,000USD | 87,923,000USD | 506,928,000USD | 108,625,000USD | 123,200,000USD | 181,148,000USD |
| Non Current Liabilities Total | 32,742,000USD | 42,288,000USD | 44,981,000USD | 53,890,000USD | 63,626,000USD | 382,050,000USD | 112,997,000USD | 82,353,000USD |
| Non Current Liabilities Other | 5,532,000USD | 5,615,000USD | — | 379,000USD | 379,000USD | 382,050,000USD | 379,000USD | 471,000USD |
| Non Currrent Assets Other | 124,261,000USD | 24,741,000USD | 18,143,000USD | 13,399,000USD | 11,871,000USD | 962,000USD | 2,659,000USD | 8,105,000USD |
| Net Working Capital | 802,307,000USD | 762,228,000USD | 986,155,000USD | 1,008,397,000USD | 518,989,000USD | 1,423,956,000USD | 384,687,000USD | 448,050,000USD |
| Unclassified Non Current Assets | -98,322,000USD | — | — | -13,399,000USD | -11,871,000USD | — | -2,659,000USD | -8,105,000USD |
| Unclassified Non Current Liabilities | 27,210,000USD | 36,673,000USD | 44,981,000USD | 52,653,000USD | 58,175,000USD | -317,875,000USD | 68,486,000USD | -6,312,000USD |
| Unclassified Equity | 3,060,827,000USD | 2,763,112,000USD | 2,143,100,000USD | 2,016,931,000USD | 1,606,690,000USD | 1,502,129,000USD | 817,515,000USD | 772,885,000USD |
| Other Assets | — | — | 1USD | 13,399,000USD | 11,871,000USD | 2,462,000USD | 2,659,000USD | 8,105,000USD |
| Current Deferred Revenue | — | — | -46,909,000USD | 290,053,000USD | 320,301,000USD | 23,483,000USD | 18,739,000USD | 11,427,000USD |
| Inventory | — | — | 1USD | -5,000,000USD | — | — | — | -8,546,000USD |
| Other Liab | — | — | — | 858,000USD | 5,072,000USD | 317,875,000USD | 44,132,000USD | 82,353,000USD |
| Net Tangible Assets | — | — | — | 1,042,430,000USD | 962,291,000USD | 1,150,531,000USD | 394,890,000USD | 546,845,000USD |
| Deferred Long Term Liab | — | — | — | — | — | — | — | 5,841,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | — | — | -19,088,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -128,447,000USD | -128,549,000USD | -126,902,000USD | -124,119,000USD | -132,970,000USD | -114,753,000USD | -107,192,000USD | -99,026,000USD |
| Depreciation | 3,761,000USD | 3,782,000USD | 2,947,000USD | 3,045,000USD | 3,212,000USD | 1,853,000USD | 1,838,000USD | 1,942,000USD |
| Stock Based Compensation | 23,087,000USD | 23,951,000USD | 25,135,000USD | 25,387,000USD | 25,160,000USD | 25,078,000USD | 24,860,000USD | 25,100,000USD |
| Other Non Cash Items | -2,109,000USD | -2,738,000USD | 22,880,000USD | 22,489,000USD | -4,937,000USD | -6,448,000USD | 15,864,000USD | -11,077,000USD |
| Change In Working Capital | -27,496,000USD | 5,016,000USD | -6,221,000USD | 23,287,000USD | -21,933,000USD | 10,555,000USD | 30,351,000USD | -8,159,000USD |
| Total Cash From Operating Activities | -131,204,000USD | -98,538,000USD | -107,296,000USD | -75,298,000USD | -131,468,000USD | -83,715,000USD | -59,139,000USD | -91,220,000USD |
| Capital Expenditures | -2,466,000USD | -1,524,000USD | 1,378,000USD | -4,278,000USD | -5,078,000USD | -5,092,000USD | -3,884,000USD | -4,786,000USD |
| Free Cash Flow | -133,670,000USD | -100,062,000USD | -105,918,000USD | -79,576,000USD | -136,546,000USD | -88,807,000USD | -63,023,000USD | -96,006,000USD |
| Investments | 96,926,000USD | 22,292,000USD | 57,830,000USD | 157,935,000USD | 18,748,000USD | 172,207,000USD | 93,655,000USD | 98,569,000USD |
| Total Cashflows From Investing Activities | 94,460,000USD | 20,768,000USD | 57,830,000USD | 157,935,000USD | 18,748,000USD | 172,207,000USD | 93,655,000USD | 98,569,000USD |
| Net Borrowings | -17,000USD | -16,000USD | -1,361,000USD | -2,434,000USD | -4,357,000USD | -8,323,000USD | -24,015,000USD | — |
| Total Cash From Financing Activities | 219,044,000USD | 192,133,000USD | -778,000USD | 1,623,000USD | -3,762,000USD | -4,168,000USD | -18,559,000USD | 6,756,000USD |
| Change In Cash | 182,300,000USD | 114,363,000USD | -50,244,000USD | 84,260,000USD | -116,482,000USD | 84,324,000USD | 15,957,000USD | 14,105,000USD |
| Begin Period Cash Flow | 208,432,000USD | 94,069,000USD | 141,207,000USD | 56,947,000USD | 176,535,000USD | 92,211,000USD | 74,679,000USD | 60,574,000USD |
| End Period Cash Flow | 390,732,000USD | 208,432,000USD | 90,963,000USD | 141,207,000USD | 60,053,000USD | 176,535,000USD | 90,636,000USD | 74,679,000USD |
| Other Cashflows From Financing Activities | 200,000,000USD | 192,133,000USD | -778,000USD | 1,623,000USD | 595,000USD | 4,155,000USD | -18,559,000USD | 6,756,000USD |
| Unclassified Financing Cash Flow | 19,061,000USD | -189,233,000USD | 1,361,000USD | 2,434,000USD | — | — | 24,015,000USD | — |
| Issuance Of Capital Stock | — | 189,249,000USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Unclassified Operating Cash Flow | — | — | -25,135,000USD | -25,387,000USD | — | — | -24,860,000USD | — |
| Unclassified Investing Cash Flow | — | — | -1,378,000USD | 4,278,000USD | 5,078,000USD | 5,092,000USD | 3,884,000USD | -98,569,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 103,355,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -512,540,000USD | -422,773,000USD | -145,224,000USD | -325,991,000USD | -290,581,000USD | 71,136,000USD | -197,614,000USD | -36,240,000USD |
| Depreciation | 14,812,000USD | 8,992,000USD | 16,726,000USD | 10,383,000USD | 8,593,000USD | 8,531,000USD | 7,991,000USD | 7,415,000USD |
| Stock Based Compensation | 99,633,000USD | 102,878,000USD | 108,102,000USD | 99,847,000USD | 85,247,000USD | 50,351,000USD | 38,378,000USD | 18,791,000USD |
| Other Non Cash Items | -14,654,000USD | -53,728,000USD | -47,669,000USD | -4,925,000USD | 5,764,000USD | -2,322,000USD | -3,253,000USD | -2,741,000USD |
| Change In Working Capital | 149,000USD | 16,937,000USD | -289,926,000USD | -24,030,000USD | -20,412,000USD | 288,401,000USD | 2,922,000USD | 62,891,000USD |
| Total Cash From Operating Activities | -412,600,000USD | -347,694,000USD | -357,991,000USD | -244,716,000USD | -211,389,000USD | 416,152,000USD | -151,576,000USD | 50,116,000USD |
| Capital Expenditures | -9,502,000USD | -15,912,000USD | -12,939,000USD | -17,833,000USD | -8,500,000USD | -3,095,000USD | -17,919,000USD | -3,393,000USD |
| Free Cash Flow | -422,102,000USD | -363,606,000USD | -370,930,000USD | -262,549,000USD | -219,889,000USD | 413,057,000USD | -169,495,000USD | 46,723,000USD |
| Investments | 264,783,000USD | -88,756,000USD | 48,702,000USD | -141,387,000USD | -13,126,000USD | -620,111,000USD | 165,631,000USD | -284,029,000USD |
| Total Cashflows From Investing Activities | 255,281,000USD | -88,756,000USD | 249,308,000USD | -141,387,000USD | -21,626,000USD | -623,206,000USD | 147,712,000USD | -287,422,000USD |
| Net Borrowings | -8,168,000USD | -32,338,000USD | 0USD | 0USD | — | — | — | — |
| Total Cash From Financing Activities | 189,216,000USD | 484,304,000USD | 17,820,000USD | 310,670,000USD | 19,348,000USD | 634,749,000USD | 6,190,000USD | 97,019,000USD |
| Issuance Of Capital Stock | 189,249,000USD | 499,253,000USD | 0USD | 296,215,000USD | 0USD | 614,094,000USD | 193,948,000USD | 94,406,000USD |
| Change In Cash | 31,897,000USD | 47,854,000USD | -90,938,000USD | -75,433,000USD | -213,667,000USD | 427,695,000USD | 2,326,000USD | -140,287,000USD |
| Begin Period Cash Flow | 176,535,000USD | 128,681,000USD | 218,044,000USD | 294,977,000USD | 508,644,000USD | 80,949,000USD | 78,623,000USD | 218,910,000USD |
| End Period Cash Flow | 208,432,000USD | 176,535,000USD | 127,106,000USD | 219,544,000USD | 294,977,000USD | 508,644,000USD | 80,949,000USD | 78,623,000USD |
| Other Cashflows From Financing Activities | 189,216,000USD | 17,389,000USD | 17,820,000USD | 14,455,000USD | 19,348,000USD | 20,655,000USD | 6,190,000USD | 2,613,000USD |
| Unclassified Financing Cash Flow | -181,081,000USD | — | — | — | -19,348,000USD | 399,491,000USD | -6,190,000USD | 91,793,000USD |
| Unclassified Investing Cash Flow | — | 15,912,000USD | 213,545,000USD | 141,387,000USD | 13,126,000USD | 620,111,000USD | -165,631,000USD | 284,029,000USD |
| Change To Liabilities | — | — | — | -32,188,000USD | -11,957,000USD | 20,805,000USD | 2,533,000USD | 8,966,000USD |
| Other Cashflows From Investing Activities | — | — | — | -123,554,000USD | -13,126,000USD | -620,111,000USD | 165,631,000USD | -284,029,000USD |
| Sale Purchase Of Stock | — | — | — | — | 19,348,000USD | 214,603,000USD | 6,190,000USD | 2,613,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | -213,667,000USD | 427,695,000USD | 2,326,000USD | -140,287,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2023Yearly · 2023-12-31 | Product | ATVAbeta Option Material Right | 293,912,000 | USD | 0001714899-26-000021 |
| FY 2023Yearly · 2023-12-31 | Product | Option Services | 1,619,000 | USD | 0001714899-26-000021 |
| Q3 2023Quarterly · 2023-09-30 | Product | ATVAbeta Program License | 0 | USD | 0001714899-23-000146 |
| Q3 2023Quarterly · 2023-09-30 | Product | CNSProgram License | 0 | USD | 0001714899-23-000146 |
| Q3 2023Quarterly · 2023-09-30 | Product | Collaboration Agreement Services | 0 | USD | 0001714899-23-000146 |
| Q3 2023Quarterly · 2023-09-30 | Product | Option Services | 1,267,000 | USD | 0001714899-23-000146 |
| Q3 2023Quarterly · 2023-09-30 | Product | PTVPGRNServices | 0 | USD | 0001714899-23-000146 |
| Q2 2023Quarterly · 2023-06-30 | Product | ATVAbeta Program License | 293,912,000 | USD | 0001714899-23-000120 |
| Q2 2023Quarterly · 2023-06-30 | Product | CNSProgram License | 0 | USD | 0001714899-23-000120 |
| Q2 2023Quarterly · 2023-06-30 | Product | Collaboration Agreement Services | 0 | USD | 0001714899-23-000120 |
| Q2 2023Quarterly · 2023-06-30 | Product | Option Services | 211,000 | USD | 0001714899-23-000120 |
| Q2 2023Quarterly · 2023-06-30 | Product | PTVPGRNServices | 0 | USD | 0001714899-23-000120 |
| Q1 2023Quarterly · 2023-03-31 | Product | CNSProgram License | 25,000,000 | USD | 0001714899-24-000121 |
| Q1 2023Quarterly · 2023-03-31 | Product | Option Services | 141,000 | USD | 0001714899-24-000121 |
| Q1 2023Quarterly · 2023-03-31 | Product | PTVPGRNServices | 10,000,000 | USD | 0001714899-24-000121 |
| FY 2022Yearly · 2022-12-31 | Product | ATVAbeta Option Material Right | 0 | USD | 0001714899-24-000086 |
| FY 2022Yearly · 2022-12-31 | Product | CNSProgram License | 40,000,000 | USD | 0001714899-24-000086 |
| FY 2022Yearly · 2022-12-31 | Product | Collaboration Agreement Services | 51,916,000 | USD | 0001714899-24-000086 |
| FY 2022Yearly · 2022-12-31 | Product | Collaborative Arrangement ATVTREM2 | 0 | USD | 0001714899-24-000086 |
| FY 2022Yearly · 2022-12-31 | Product | Collaborative Arrangement PTVPGRN | 0 | USD | 0001714899-24-000086 |
| FY 2022Yearly · 2022-12-31 | Product | Option Services | 3,149,000 | USD | 0001714899-24-000086 |
| FY 2022Yearly · 2022-12-31 | Product | Peripheral Product | 10,000,000 | USD | 0001714899-24-000086 |
| Q3 2022Quarterly · 2022-09-30 | Product | ATVAbeta Program License | 0 | USD | 0001714899-23-000146 |
| Q3 2022Quarterly · 2022-09-30 | Product | CNSProgram License | 0 | USD | 0001714899-23-000146 |
| Q3 2022Quarterly · 2022-09-30 | Product | Collaboration Agreement Services | 0 | USD | 0001714899-23-000146 |
| Q3 2022Quarterly · 2022-09-30 | Product | Option Services | 184,000 | USD | 0001714899-23-000146 |
| Q3 2022Quarterly · 2022-09-30 | Product | PTVPGRNServices | 0 | USD | 0001714899-23-000146 |
| Q2 2022Quarterly · 2022-06-30 | Product | ATVAbeta Program License | 0 | USD | 0001714899-23-000120 |
| Q2 2022Quarterly · 2022-06-30 | Product | CNSProgram License | 40,000,000 | USD | 0001714899-23-000120 |
| Q2 2022Quarterly · 2022-06-30 | Product | Collaboration Agreement Services | 12,000,000 | USD | 0001714899-23-000120 |
| Q2 2022Quarterly · 2022-06-30 | Product | Option Services | 480,000 | USD | 0001714899-23-000120 |
| Q2 2022Quarterly · 2022-06-30 | Product | PTVPGRNServices | 0 | USD | 0001714899-23-000120 |
| Q1 2022Quarterly · 2022-03-31 | Product | CNSProgram License | 0 | USD | 0001714899-23-000075 |
| Q1 2022Quarterly · 2022-03-31 | Product | Collaboration Agreement Services | 39,916,000 | USD | 0001714899-23-000075 |
| Q1 2022Quarterly · 2022-03-31 | Product | Option Services | 2,225,000 | USD | 0001714899-23-000075 |
| Q1 2022Quarterly · 2022-03-31 | Product | PTVPGRNServices | 0 | USD | 0001714899-23-000075 |
| FY 2021Yearly · 2021-12-31 | Product | CNSProgram License | 0 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | Collaboration Agreement Services | 19,921,000 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | Collaborative Arrangement ATVTREM2 | 5,000,000 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | Collaborative Arrangement PTVPGRN | 5,000,000 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | LRRK2Product | 0 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | Option Services | 3,736,000 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | Peripheral Product | 15,000,000 | USD | 0001714899-23-000049 |
| FY 2021Yearly · 2021-12-31 | Product | Retained Activities | 0 | USD | 0001714899-23-000049 |
| Q3 2021Quarterly · 2021-09-30 | Product | CNSProgram License | 0 | USD | 0001714899-22-000144 |
| Q3 2021Quarterly · 2021-09-30 | Product | Collaboration Agreement Services | 4,425,000 | USD | 0001714899-22-000144 |
| Q3 2021Quarterly · 2021-09-30 | Product | Option Services | 860,000 | USD | 0001714899-22-000144 |
| Q3 2021Quarterly · 2021-09-30 | Product | Peripheral Product | 0 | USD | 0001714899-22-000144 |
| Q2 2021Quarterly · 2021-06-30 | Product | CNSProgram License | 0 | USD | 0001714899-22-000123 |
| Q2 2021Quarterly · 2021-06-30 | Product | Collaboration Agreement Services | 7,142,000 | USD | 0001714899-22-000123 |
| Q2 2021Quarterly · 2021-06-30 | Product | Option Services | 794,000 | USD | 0001714899-22-000123 |
| Q2 2021Quarterly · 2021-06-30 | Product | Peripheral Product | 15,000,000 | USD | 0001714899-22-000123 |
| FY 2020Yearly · 2020-12-31 | Product | CNSProgram License | 0 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | Collaboration Agreement Services | 27,155,000 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | Collaborative Arrangement ATVTREM2 | 0 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | Collaborative Arrangement PTVPGRN | 0 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | LRRK2Product | 306,545,000 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | Option Services | 892,000 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | Peripheral Product | 0 | USD | 0001714899-23-000049 |
| FY 2020Yearly · 2020-12-31 | Product | Retained Activities | 969,000 | USD | 0001714899-23-000049 |
| FY 2019Yearly · 2019-12-31 | Product | ATVTREM2Services | 0 | USD | 0001714899-22-000058 |
| FY 2019Yearly · 2019-12-31 | Product | Collaboration Agreement Services | 5,926,000 | USD | 0001714899-22-000058 |
| FY 2019Yearly · 2019-12-31 | Product | LRRK2Product | 0 | USD | 0001714899-22-000058 |
| FY 2019Yearly · 2019-12-31 | Product | Option Services | 0 | USD | 0001714899-22-000058 |
| FY 2019Yearly · 2019-12-31 | Product | Peripheral Product | 10,000,000 | USD | 0001714899-22-000058 |
| FY 2019Yearly · 2019-12-31 | Product | PTVPGRNServices | 0 | USD | 0001714899-22-000058 |
| FY 2019Yearly · 2019-12-31 | Product | Retained Activities | 10,394,000 | USD | 0001714899-22-000058 |
| FY 2018Yearly · 2018-12-31 | Product | CNSProgram License | 73,932,000 | USD | 0001714899-21-000033 |
| FY 2018Yearly · 2018-12-31 | Product | LRRK2Product | 0 | USD | 0001714899-21-000033 |
| FY 2018Yearly · 2018-12-31 | Product | Option Services | 0 | USD | 0001714899-21-000033 |
| FY 2018Yearly · 2018-12-31 | Product | Other | 5,677,000 | USD | 0001714899-21-000033 |
| FY 2018Yearly · 2018-12-31 | Product | Peripheral Product | 47,148,000 | USD | 0001714899-21-000033 |
| FY 2018Yearly · 2018-12-31 | Product | Retained Activities | 2,343,000 | USD | 0001714899-21-000033 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.